Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Treasury Shares (2019 - 2025)

Organogenesis Holdings (ORGO) has 7 years of Treasury Shares data on record, last reported at $5.5 million in Q4 2025.

  • For Q4 2025, Treasury Shares rose 21.22% year-over-year to $5.5 million; the TTM value through Dec 2025 reached $5.5 million, up 21.22%, while the annual FY2025 figure was $5.5 million, 21.22% up from the prior year.
  • Treasury Shares reached $5.5 million in Q4 2025 per ORGO's latest filing, up from $198900.0 in the prior quarter.
  • Across five years, Treasury Shares topped out at $5.5 million in Q4 2025 and bottomed at $198900.0 in Q2 2025.
  • Average Treasury Shares over 5 years is $2.4 million, with a median of $1.5 million recorded in 2022.
  • Peak YoY movement for Treasury Shares: skyrocketed 182.28% in 2023, then tumbled 95.4% in 2025.
  • A 5-year view of Treasury Shares shows it stood at $764871.0 in 2021, then skyrocketed by 80.62% to $1.4 million in 2022, then skyrocketed by 182.18% to $3.9 million in 2023, then rose by 16.19% to $4.5 million in 2024, then grew by 21.22% to $5.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Treasury Shares were $5.5 million in Q4 2025, $198900.0 in Q3 2025, and $198900.0 in Q2 2025.